Advertisement

Metastatic Esophageal Adenocarcinoma of the Great Toe: A Case Report

  • Said Atway
    Correspondence
    Address correspondence to: Said Atway, DPM, Clinical Assistant Professor of Orthopaedics, Section of Podiatry, Department of Orthopaedics and Podiatry, Ohio State University, 410 West 10th Avenue, Doan Hall, N1050, Columbus, OH 43210-1240.
    Affiliations
    Clinical Assistant Professor of Orthopaedics, Section of Podiatry, Department of Orthopaedics and Podiatry, Ohio State University, Columbus, OH
    Search for articles by this author
  • Robert Vancourt
    Affiliations
    Private Physician, Advanced Ankle and Foot Center, Powell, OH
    Search for articles by this author
Published:December 08, 2011DOI:https://doi.org/10.1053/j.jfas.2011.10.031

      Abstract

      Owing to the rarity of metastatic disease to the bones of the foot, the guidelines for the proper care and workup of such conditions are inconsistent. The present case illustrates the evaluation of a patient with established esophageal adenocarcinoma that metastasized to involve the hallux, which had not been confirmed by previous imaging scans. The purpose of reporting the present case was to aid in establishing a protocol for a multidisciplinary approach to patient care and evaluating the entire body when performing metastatic disease treatment. As the present case has shown, evaluation of various abnormalities such as chronic paronychia could mask additional underlying conditions related to the patient’s primary cancer.

      Level of Clinical Evidence

      Keywords

      To read this article in full you will need to make a payment

      References

        • Zindrick M.R.
        • Young M.P.
        • Daley R.J.
        • Light T.R.
        Metastatic tumors of the foot: case report and literature review.
        Clin Orthop Rel Res. 1982; 170: 219-225
        • Gall R.J.
        • Sim F.H.
        • Pritchard D.J.
        Metastatic tumors to the bones of the foot.
        Cancer. 1976; 37: 1492-1495
        • Kumar V.
        • Fausto N.
        • Abbas A.
        Robbins and Cotran: Pathologic Basis of Disease.
        7th ed. WB Saunders, Philadelphia2004
        • Enzinger P.C.
        • Mayer R.J.
        Esophageal cancer.
        N Engl J Med. 2003; 349: 2241-2252
        • Lightdale C.J.
        Esophageal cancer.
        Am J Gastroenterol. 1999; 94: 20-29
        • Jones D.R.
        • Parker L.A.
        • Detterbeck F.C.
        • Egan T.M.
        Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy.
        Cancer. 1999; 85: 1026-1032
        • Aisner J.A.
        • Forastiere A.
        • Aroney R.
        Patterns of recurrence for cancer of the lung and esophagus.
        Cancer Treat Symp. 1983; 2: 87-105
        • Flamen P.
        • Van Cutsem E.
        • Lerut A.
        • Cambier J.P.
        • Haustermans K.
        • Bormans G.
        • De Leyn P.
        • Van Raemdonck D.
        • De Wever W.
        • Ectors N.
        • Maes A.
        • Mortelmans L.
        Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.
        Ann Oncol. 2002; 13: 361-368
        • Brady L.W.
        • O’Neil E.A.
        • Farber S.H.
        Unusual sites of metastases.
        Semin Oncol. 1977; 4: 59-64
        • Cohen P.R.
        Metastatic tumors to the nail unit: subungual metastases.
        Dermatol Surg. 2001; 27: 280-293
        • Healy J.H.
        • Turnbull A.D.
        • Miedema B.
        • Lane J.M.
        Acrometastases: a study of twenty-nine patients with osseous involvement of the hands and feet.
        J Bone Joint Surg Am. 1986; 68: 743-746
        • Berrettoni B.A.
        • Carter J.R.
        Mechanisms of cancer metastasis to bone.
        J Bone Joint Surg. 1986; 68: 743-746
        • Gallagher B.
        • Yousef G.
        • Bishop L.
        Subungual metastasis from a rectal primary: case report and review of the literature.
        Dermatol Surg. 2006; 32: 592-595
        • Rich P.
        Nail biopsy. indications and methods.
        Dermatol Surg. 2001; 27: 229-234
        • Rice T.W.
        Clinical staging of esophageal carcinoma: CT, EUS, and PET.
        Chest Surg Clin North Am. 2000; 10: 471-485
        • Jones D.R.
        • Parker L.A.
        • Detterbeck F.C.
        • Egan T.M.
        Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy.
        Cancer. 1999; 85: 1026-1032
        • Meltzer C.C.
        • Luketich J.D.
        Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
        Clin Nucl Med. 2000; 25: 882-887
        • Weber W.A.
        • Ott K.
        • Becker K.
        • Dittler H.-J.
        • Helmberger H.
        • Avril N.E.
        • Meisetschläger G.
        • Busch R.
        • Siewert J.-R.
        • Schwaiger M.
        • Fink U.
        Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.
        J Clin Oncol. 2001; 19: 3058-3065
        • Ott K.
        • Weber W.A.
        • Lordick F.
        • Ott K.
        • Weber W.A.
        • Lordick F.
        • Becker K.
        • Busch R.
        • Herrmann K.
        • Wieder H.
        • Fink U.
        • Schwaiger M.
        • Siewert J.-R.
        Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
        J Clin Oncol. 2006; 24: 4692-4698
        • Block M.I.
        • Patterson G.A.
        • Sundaresan R.S.
        • Bailey M.S.
        • Flanagan F.L.
        • Dehdashti F.
        • Siegel B.A.
        • Cooper J.D.
        Improvement in staging of esophageal cancer with addition of positron emission tomography.
        Ann Thorac Surg. 1997; 64: 770-776